Aderamastat
5-[3-[4-[(3-methylphenyl)methoxy]phenyl]sulfanylfuran-2-yl]imidazolidine-2,4-dione
Molecular Identity
Aderamastat
5-[3-[4-[(3-methylphenyl)methoxy]phenyl]sulfanylfuran-2-yl]imidazolidine-2,4-dione
PubChem CID: 67177374
2D Structure
Properties
C21H18N2O4S
Molecular Formula
394.40
Molecular Weight
g/mol
394.0987
Exact Mass
Da
3.7
XLogP
Drug-like (Lipinski: < 5)
106
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
5
H-Bond Acceptors
567
Complexity
SMILES
Canonical SMILES
SMILES: CC1=CC(=CC=C1)COC2=CC=C(C=C2)SC3=C(OC=C3)C4C(=O)NC(=O)N4Isomeric SMILES
SMILES: CC1=CC(=CC=C1)COC2=CC=C(C=C2)SC3=C(OC=C3)C4C(=O)NC(=O)N4Synonyms(20)
Aderamastat877176-23-3FP-025FP0252IZ5925NZQFP-003RefChem:915169inhibitor of MMP-12 FP-025FP003FP 003FP 025FP-025 (C21H18N2O4S)2,4-Imidazolidinedione, 5-[3-[[4-[(3-methylphenyl)methoxy]phenyl]thio]-2-furanyl]-5-(3-((4-((3-methylbenzyl)oxy)phenyl)thio)furan-2-yl)imidazolidine-2,4-dioneAderamastat (USAN/INN)
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Aderamastat
Loading drug network...